APO Research
Talk to an analyst

APO RESEARCH · REPORT

RNA Synthesis

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global RNA Synthesis Market Analysis and Forecast 2026-2032

4 June 2026245 pages

Choose your research edition.

Industry ResearchRNA Synthesis Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal RNA Synthesis Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal RNA Synthesis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RNA Synthesis Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal RNA Synthesis Market Analysis and Forecast 2026-2032245 pages · $4,950 USD

Market perspective

The global RNA Synthesis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for RNA Synthesis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for RNA Synthesis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for RNA Synthesis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for RNA Synthesis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of RNA Synthesis include GenScript, Hokkaido System Science, Bio-Synthesis, IDT, Thermo Fisher Scientific, Genewiz, Gene Universal, TriLink BioTechnologies and GE Healthcare Dharmacon, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for RNA Synthesis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of RNA Synthesis, also provides the revenue of main regions and countries. Of the upcoming market potential for RNA Synthesis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the RNA Synthesis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global RNA Synthesis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for RNA Synthesis revenue, projected growth trends, production technology, application and end-user industry.

RNA Synthesis Segment by Company

GenScript

Hokkaido System Science

Bio-Synthesis

IDT

Thermo Fisher Scientific

Genewiz

Gene Universal

TriLink BioTechnologies

GE Healthcare Dharmacon

ChemGenes

Creative Biolabs

Glen Research

VeliterBio

Creative Biogene

Merck

Eurofins Scientific

RNA Synthesis Segment by Type

mRNA Synthesis

tRNA Synthesis

rRNA Synthesis

siRNA Synthesis

RNA Synthesis Segment by Application

Biomedical Science

Pharmaceutical

Others

RNA Synthesis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RNA Synthesis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RNA Synthesis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RNA Synthesis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of RNA Synthesis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of RNA Synthesis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, RNA Synthesis revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global RNA Synthesis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. mRNA Synthesis Major Player Table 3. tRNA Synthesis Major Player Table 4. rRNA Synthesis Major Player Table 5. siRNA Synthesis Major Player Table 6. Global RNA Synthesis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Biomedical Science Major Player Table 8. Pharmaceutical Major Player Table 9. Others Major Player Table 10. RNA Synthesis Industry Trends Table 11. RNA Synthesis Industry Drivers Table 12. RNA Synthesis Industry Opportunities and Challenges Table 13. RNA Synthesis Industry Restraints Table 14. Global RNA Synthesis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global RNA Synthesis Market Size by Region (2021-2026) & (US$ Million) Table 16. Global RNA Synthesis Market Share by Region (2021-2026) Table 17. Global RNA Synthesis Market Size by Region (2027-2032) & (US$ Million) Table 18. Global RNA Synthesis Market Share by Region (2027-2032) Table 19. Global RNA Synthesis Revenue by Players (US$ Million) & (2021-2026) Table 20. Global RNA Synthesis Revenue Market Share by Players (2021-2026) Table 21. Global RNA Synthesis Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global RNA Synthesis Key Players Headquarters & Area Served Table 23. Global RNA Synthesis Players, Product Type & Application Table 24. Global RNA Synthesis Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global RNA Synthesis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global RNA Synthesis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global RNA Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 29. Global RNA Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 30. Global RNA Synthesis Revenue Market Share by Type (2021-2026) Table 31. Global RNA Synthesis Revenue Market Share by Type (2027-2032) Table 32. Global RNA Synthesis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global RNA Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 34. Global RNA Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 35. Global RNA Synthesis Revenue Market Share by Application (2021-2026) Table 36. Global RNA Synthesis Revenue Market Share by Application (2027-2032) Table 37. GenScript Company Information Table 38. GenScript Business Overview Table 39. GenScript RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. GenScript RNA Synthesis Product Portfolio Table 41. GenScript Recent Development Table 42. Hokkaido System Science Company Information Table 43. Hokkaido System Science Business Overview Table 44. Hokkaido System Science RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Hokkaido System Science RNA Synthesis Product Portfolio Table 46. Hokkaido System Science Recent Development Table 47. Bio-Synthesis Company Information Table 48. Bio-Synthesis Business Overview Table 49. Bio-Synthesis RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Bio-Synthesis RNA Synthesis Product Portfolio Table 51. Bio-Synthesis Recent Development Table 52. IDT Company Information Table 53. IDT Business Overview Table 54. IDT RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. IDT RNA Synthesis Product Portfolio Table 56. IDT Recent Development Table 57. Thermo Fisher Scientific Company Information Table 58. Thermo Fisher Scientific Business Overview Table 59. Thermo Fisher Scientific RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Thermo Fisher Scientific RNA Synthesis Product Portfolio Table 61. Thermo Fisher Scientific Recent Development Table 62. Genewiz Company Information Table 63. Genewiz Business Overview Table 64. Genewiz RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Genewiz RNA Synthesis Product Portfolio Table 66. Genewiz Recent Development Table 67. Gene Universal Company Information Table 68. Gene Universal Business Overview Table 69. Gene Universal RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Gene Universal RNA Synthesis Product Portfolio Table 71. Gene Universal Recent Development Table 72. TriLink BioTechnologies Company Information Table 73. TriLink BioTechnologies Business Overview Table 74. TriLink BioTechnologies RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. TriLink BioTechnologies RNA Synthesis Product Portfolio Table 76. TriLink BioTechnologies Recent Development Table 77. GE Healthcare Dharmacon Company Information Table 78. GE Healthcare Dharmacon Business Overview Table 79. GE Healthcare Dharmacon RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. GE Healthcare Dharmacon RNA Synthesis Product Portfolio Table 81. GE Healthcare Dharmacon Recent Development Table 82. ChemGenes Company Information Table 83. ChemGenes Business Overview Table 84. ChemGenes RNA Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. ChemGenes RNA Synthesis Product Portfolio Table 86. ChemGenes Recent Development Table 87. Creative Biolabs Company Information Table 88. Creative Biolabs Business Overview Table 89. Creative Biolabs RNA Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Creative Biolabs RNA Synthesis Product Portfolio Table 91. Creative Biolabs Recent Development Table 92. Glen Research Company Information Table 93. Glen Research Business Overview Table 94. Glen Research RNA Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Glen Research RNA Synthesis Product Portfolio Table 96. Glen Research Recent Development Table 97. VeliterBio Company Information Table 98. VeliterBio Business Overview Table 99. VeliterBio RNA Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. VeliterBio RNA Synthesis Product Portfolio Table 101. VeliterBio Recent Development Table 102. Creative Biogene Company Information Table 103. Creative Biogene Business Overview Table 104. Creative Biogene RNA Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Creative Biogene RNA Synthesis Product Portfolio Table 106. Creative Biogene Recent Development Table 107. Merck Company Information Table 108. Merck Business Overview Table 109. Merck RNA Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Merck RNA Synthesis Product Portfolio Table 111. Merck Recent Development Table 112. Eurofins Scientific Company Information Table 113. Eurofins Scientific Business Overview Table 114. Eurofins Scientific RNA Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Eurofins Scientific RNA Synthesis Product Portfolio Table 116. Eurofins Scientific Recent Development Table 117. North America RNA Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 118. North America RNA Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 119. North America RNA Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 120. North America RNA Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 121. North America RNA Synthesis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America RNA Synthesis Revenue by Country (2021-2026) & (US$ Million) Table 123. North America RNA Synthesis Revenue by Country (US$ Million) & (2027-2032) Table 124. Europe RNA Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe RNA Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe RNA Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe RNA Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe RNA Synthesis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe RNA Synthesis Revenue by Country (2021-2026) & (US$ Million) Table 130. Europe RNA Synthesis Revenue by Country (US$ Million) & (2027-2032) Table 131. China RNA Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 132. China RNA Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 133. China RNA Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 134. China RNA Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia RNA Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 136. Asia RNA Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 137. Asia RNA Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 138. Asia RNA Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia RNA Synthesis Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia RNA Synthesis Revenue by Region (US$ Million) & (2021-2026) Table 141. Asia RNA Synthesis Revenue by Region (US$ Million) & (2027-2032) Table 142. SAMEA RNA Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 143. SAMEA RNA Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 144. SAMEA RNA Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 145. SAMEA RNA Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 146. SAMEA RNA Synthesis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. SAMEA RNA Synthesis Revenue by Country (2021-2026) & (US$ Million) Table 148. SAMEA RNA Synthesis Revenue by Country (US$ Million) & (2027-2032) Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. RNA Synthesis Image Figure 2. Global RNA Synthesis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global RNA Synthesis Market Size Share 2021 VS 2025 VS 2032 Figure 4. mRNA Synthesis Image Figure 5. tRNA Synthesis Image Figure 6. rRNA Synthesis Image Figure 7. siRNA Synthesis Image Figure 8. Global RNA Synthesis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global RNA Synthesis Market Size Share 2021 VS 2025 VS 2032 Figure 10. Biomedical Science Image Figure 11. Pharmaceutical Image Figure 12. Others Image Figure 13. Global RNA Synthesis Market Size (US$ Million) & (2021-2032) Figure 14. Global RNA Synthesis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global RNA Synthesis Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global RNA Synthesis Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global RNA Synthesis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global RNA Synthesis Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global RNA Synthesis Revenue Market Share by Type (2021-2032) Figure 21. Global RNA Synthesis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global RNA Synthesis Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global RNA Synthesis Revenue Market Share by Application (2021-2032) Figure 24. North America RNA Synthesis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America RNA Synthesis Revenue Share by Type (2021-2032) Figure 26. North America RNA Synthesis Revenue Share by Application (2021-2032) Figure 27. North America RNA Synthesis Revenue Share by Country (2021-2032) Figure 28. United States RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe RNA Synthesis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe RNA Synthesis Revenue Share by Type (2021-2032) Figure 33. Europe RNA Synthesis Revenue Share by Application (2021-2032) Figure 34. Europe RNA Synthesis Revenue Share by Country (2021-2032) Figure 35. Germany RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China RNA Synthesis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China RNA Synthesis Revenue Share by Type (2021-2032) Figure 45. China RNA Synthesis Revenue Share by Application (2021-2032) Figure 46. Asia RNA Synthesis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia RNA Synthesis Revenue Share by Type (2021-2032) Figure 48. Asia RNA Synthesis Revenue Share by Application (2021-2032) Figure 49. Asia RNA Synthesis Revenue Share by Region (2021-2032) Figure 50. Japan RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA RNA Synthesis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA RNA Synthesis Revenue Share by Type (2021-2032) Figure 58. SAMEA RNA Synthesis Revenue Share by Application (2021-2032) Figure 59. SAMEA RNA Synthesis Revenue Share by Country (2021-2032) Figure 60. Brazil RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt RNA Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • mRNA Synthesis
  • tRNA Synthesis
  • rRNA Synthesis
  • siRNA Synthesis
Applications
  • Biomedical Science
  • Pharmaceutical
  • Others
Companies covered
  • GenScript
  • Hokkaido System Science
  • Bio-Synthesis
  • IDT
  • Thermo Fisher Scientific
  • Genewiz
  • Gene Universal
  • TriLink BioTechnologies
  • GE Healthcare Dharmacon
  • ChemGenes
  • Creative Biolabs
  • Glen Research
  • VeliterBio
  • Creative Biogene
  • Merck
  • Eurofins Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 RNA Synthesis Market by Type
  3. 1.2.1 Global RNA Synthesis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 mRNA Synthesis
  5. 1.2.3 tRNA Synthesis
  6. 1.2.4 rRNA Synthesis
  7. 1.2.5 siRNA Synthesis
  8. 1.3 RNA Synthesis Market by Application
  9. 1.3.1 Global RNA Synthesis Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Biomedical Science
  11. 1.3.3 Pharmaceutical
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 RNA Synthesis Market Dynamics
  1. 2.1 RNA Synthesis Industry Trends
  2. 2.2 RNA Synthesis Industry Drivers
  3. 2.3 RNA Synthesis Industry Opportunities and Challenges
  4. 2.4 RNA Synthesis Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global RNA Synthesis Market Perspective (2021-2032)
  2. 3.2 Global RNA Synthesis Growth Trends by Region
  3. 3.2.1 Global RNA Synthesis Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global RNA Synthesis Market Size by Region (2021-2026)
  5. 3.2.3 Global RNA Synthesis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global RNA Synthesis Revenue by Players
  2. 4.1.1 Global RNA Synthesis Revenue by Players (2021-2026)
  3. 4.1.2 Global RNA Synthesis Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global RNA Synthesis Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global RNA Synthesis Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global RNA Synthesis Key Players Headquarters & Area Served
  7. 4.4 Global RNA Synthesis Players, Product Type & Application
  8. 4.5 Global RNA Synthesis Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global RNA Synthesis Market CR5 and HHI
  11. 4.6.3 2025 RNA Synthesis Tier 1, Tier 2, and Tier 3
5 RNA Synthesis Market Size by Type
  1. 5.1 Global RNA Synthesis Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global RNA Synthesis Revenue by Type (2021-2032)
  3. 5.3 Global RNA Synthesis Revenue Market Share by Type (2021-2032)
6 RNA Synthesis Market Size by Application
  1. 6.1 Global RNA Synthesis Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global RNA Synthesis Revenue by Application (2021-2032)
  3. 6.3 Global RNA Synthesis Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 GenScript
  2. 7.1.1 GenScript Company Information
  3. 7.1.2 GenScript Business Overview
  4. 7.1.3 GenScript RNA Synthesis Revenue and Gross Margin (2021-2026)
  5. 7.1.4 GenScript RNA Synthesis Product Portfolio
  6. 7.1.5 GenScript Recent Developments
  7. 7.2 Hokkaido System Science
  8. 7.2.1 Hokkaido System Science Company Information
  9. 7.2.2 Hokkaido System Science Business Overview
  10. 7.2.3 Hokkaido System Science RNA Synthesis Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Hokkaido System Science RNA Synthesis Product Portfolio
  12. 7.2.5 Hokkaido System Science Recent Developments
  13. 7.3 Bio-Synthesis
  14. 7.3.1 Bio-Synthesis Company Information
  15. 7.3.2 Bio-Synthesis Business Overview
  16. 7.3.3 Bio-Synthesis RNA Synthesis Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bio-Synthesis RNA Synthesis Product Portfolio
  18. 7.3.5 Bio-Synthesis Recent Developments
  19. 7.4 IDT
  20. 7.4.1 IDT Company Information
  21. 7.4.2 IDT Business Overview
  22. 7.4.3 IDT RNA Synthesis Revenue and Gross Margin (2021-2026)
  23. 7.4.4 IDT RNA Synthesis Product Portfolio
  24. 7.4.5 IDT Recent Developments
  25. 7.5 Thermo Fisher Scientific
  26. 7.5.1 Thermo Fisher Scientific Company Information
  27. 7.5.2 Thermo Fisher Scientific Business Overview
  28. 7.5.3 Thermo Fisher Scientific RNA Synthesis Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Thermo Fisher Scientific RNA Synthesis Product Portfolio
  30. 7.5.5 Thermo Fisher Scientific Recent Developments
  31. 7.6 Genewiz
  32. 7.6.1 Genewiz Company Information
  33. 7.6.2 Genewiz Business Overview
  34. 7.6.3 Genewiz RNA Synthesis Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Genewiz RNA Synthesis Product Portfolio
  36. 7.6.5 Genewiz Recent Developments
  37. 7.7 Gene Universal
  38. 7.7.1 Gene Universal Company Information
  39. 7.7.2 Gene Universal Business Overview
  40. 7.7.3 Gene Universal RNA Synthesis Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Gene Universal RNA Synthesis Product Portfolio
  42. 7.7.5 Gene Universal Recent Developments
  43. 7.8 TriLink BioTechnologies
  44. 7.8.1 TriLink BioTechnologies Company Information
  45. 7.8.2 TriLink BioTechnologies Business Overview
  46. 7.8.3 TriLink BioTechnologies RNA Synthesis Revenue and Gross Margin (2021-2026)
  47. 7.8.4 TriLink BioTechnologies RNA Synthesis Product Portfolio
  48. 7.8.5 TriLink BioTechnologies Recent Developments
  49. 7.9 GE Healthcare Dharmacon
  50. 7.9.1 GE Healthcare Dharmacon Company Information
  51. 7.9.2 GE Healthcare Dharmacon Business Overview
  52. 7.9.3 GE Healthcare Dharmacon RNA Synthesis Revenue and Gross Margin (2021-2026)
  53. 7.9.4 GE Healthcare Dharmacon RNA Synthesis Product Portfolio
  54. 7.9.5 GE Healthcare Dharmacon Recent Developments
  55. 7.10 ChemGenes
  56. 7.10.1 ChemGenes Company Information
  57. 7.10.2 ChemGenes Business Overview
  58. 7.10.3 ChemGenes RNA Synthesis Revenue and Gross Margin (2021-2026)
  59. 7.10.4 ChemGenes RNA Synthesis Product Portfolio
  60. 7.10.5 ChemGenes Recent Developments
  61. 7.11 Creative Biolabs
  62. 7.11.1 Creative Biolabs Company Information
  63. 7.11.2 Creative Biolabs Business Overview
  64. 7.11.3 Creative Biolabs RNA Synthesis Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Creative Biolabs RNA Synthesis Product Portfolio
  66. 7.11.5 Creative Biolabs Recent Developments
  67. 7.12 Glen Research
  68. 7.12.1 Glen Research Company Information
  69. 7.12.2 Glen Research Business Overview
  70. 7.12.3 Glen Research RNA Synthesis Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Glen Research RNA Synthesis Product Portfolio
  72. 7.12.5 Glen Research Recent Developments
  73. 7.13 VeliterBio
  74. 7.13.1 VeliterBio Company Information
  75. 7.13.2 VeliterBio Business Overview
  76. 7.13.3 VeliterBio RNA Synthesis Revenue and Gross Margin (2021-2026)
  77. 7.13.4 VeliterBio RNA Synthesis Product Portfolio
  78. 7.13.5 VeliterBio Recent Developments
  79. 7.14 Creative Biogene
  80. 7.14.1 Creative Biogene Company Information
  81. 7.14.2 Creative Biogene Business Overview
  82. 7.14.3 Creative Biogene RNA Synthesis Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Creative Biogene RNA Synthesis Product Portfolio
  84. 7.14.5 Creative Biogene Recent Developments
  85. 7.15 Merck
  86. 7.15.1 Merck Company Information
  87. 7.15.2 Merck Business Overview
  88. 7.15.3 Merck RNA Synthesis Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Merck RNA Synthesis Product Portfolio
  90. 7.15.5 Merck Recent Developments
  91. 7.16 Eurofins Scientific
  92. 7.16.1 Eurofins Scientific Company Information
  93. 7.16.2 Eurofins Scientific Business Overview
  94. 7.16.3 Eurofins Scientific RNA Synthesis Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Eurofins Scientific RNA Synthesis Product Portfolio
  96. 7.16.5 Eurofins Scientific Recent Developments
8 North America
  1. 8.1 North America RNA Synthesis Revenue (2021-2032)
  2. 8.2 North America RNA Synthesis Revenue by Type (2021-2032)
  3. 8.2.1 North America RNA Synthesis Revenue by Type (2021-2026)
  4. 8.2.2 North America RNA Synthesis Revenue by Type (2027-2032)
  5. 8.3 North America RNA Synthesis Revenue Share by Type (2021-2032)
  6. 8.4 North America RNA Synthesis Revenue by Application (2021-2032)
  7. 8.4.1 North America RNA Synthesis Revenue by Application (2021-2026)
  8. 8.4.2 North America RNA Synthesis Revenue by Application (2027-2032)
  9. 8.5 North America RNA Synthesis Revenue Share by Application (2021-2032)
  10. 8.6 North America RNA Synthesis Revenue by Country
  11. 8.6.1 North America RNA Synthesis Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America RNA Synthesis Revenue by Country (2021-2026)
  13. 8.6.3 North America RNA Synthesis Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe RNA Synthesis Revenue (2021-2032)
  2. 9.2 Europe RNA Synthesis Revenue by Type (2021-2032)
  3. 9.2.1 Europe RNA Synthesis Revenue by Type (2021-2026)
  4. 9.2.2 Europe RNA Synthesis Revenue by Type (2027-2032)
  5. 9.3 Europe RNA Synthesis Revenue Share by Type (2021-2032)
  6. 9.4 Europe RNA Synthesis Revenue by Application (2021-2032)
  7. 9.4.1 Europe RNA Synthesis Revenue by Application (2021-2026)
  8. 9.4.2 Europe RNA Synthesis Revenue by Application (2027-2032)
  9. 9.5 Europe RNA Synthesis Revenue Share by Application (2021-2032)
  10. 9.6 Europe RNA Synthesis Revenue by Country
  11. 9.6.1 Europe RNA Synthesis Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe RNA Synthesis Revenue by Country (2021-2026)
  13. 9.6.3 Europe RNA Synthesis Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China RNA Synthesis Revenue (2021-2032)
  2. 10.2 China RNA Synthesis Revenue by Type (2021-2032)
  3. 10.2.1 China RNA Synthesis Revenue by Type (2021-2026)
  4. 10.2.2 China RNA Synthesis Revenue by Type (2027-2032)
  5. 10.3 China RNA Synthesis Revenue Share by Type (2021-2032)
  6. 10.4 China RNA Synthesis Revenue by Application (2021-2032)
  7. 10.4.1 China RNA Synthesis Revenue by Application (2021-2026)
  8. 10.4.2 China RNA Synthesis Revenue by Application (2027-2032)
  9. 10.5 China RNA Synthesis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia RNA Synthesis Revenue (2021-2032)
  2. 11.2 Asia RNA Synthesis Revenue by Type (2021-2032)
  3. 11.2.1 Asia RNA Synthesis Revenue by Type (2021-2026)
  4. 11.2.2 Asia RNA Synthesis Revenue by Type (2027-2032)
  5. 11.3 Asia RNA Synthesis Revenue Share by Type (2021-2032)
  6. 11.4 Asia RNA Synthesis Revenue by Application (2021-2032)
  7. 11.4.1 Asia RNA Synthesis Revenue by Application (2021-2026)
  8. 11.4.2 Asia RNA Synthesis Revenue by Application (2027-2032)
  9. 11.5 Asia RNA Synthesis Revenue Share by Application (2021-2032)
  10. 11.6 Asia RNA Synthesis Revenue by Country
  11. 11.6.1 Asia RNA Synthesis Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia RNA Synthesis Revenue by Country (2021-2026)
  13. 11.6.3 Asia RNA Synthesis Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA RNA Synthesis Revenue (2021-2032)
  2. 12.2 SAMEA RNA Synthesis Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA RNA Synthesis Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA RNA Synthesis Revenue by Type (2027-2032)
  5. 12.3 SAMEA RNA Synthesis Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA RNA Synthesis Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA RNA Synthesis Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA RNA Synthesis Revenue by Application (2027-2032)
  9. 12.5 SAMEA RNA Synthesis Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA RNA Synthesis Revenue by Country
  11. 12.6.1 SAMEA RNA Synthesis Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA RNA Synthesis Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA RNA Synthesis Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst